Your prediction
Protalix Biotherapeutics Inc. Stock
Heavy losses for Protalix Biotherapeutics Inc. today as the stock fell by -€0.070 (-3.350%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | -3.350% | 0.000% | 4.239% | 60.769% | 36.601% | 43.544% | 53.676% |
| Compugen Ltd. | 2.050% | -1.942% | 7.447% | 53.495% | 53.495% | 117.204% | -62.936% |
| Chromadex Corp | 2.880% | -1.429% | 0.000% | -66.341% | -49.818% | 84.000% | -62.192% |
| Intellia Therapeutics Inc | 1.870% | -1.332% | -35.020% | -10.751% | 23.367% | -74.935% | -91.945% |
